Pharmacological treatment for metabolic dysfunction–associated steatotic liver disease and related disorders: Current and emerging therapeutic options
Chinese University of Hong Kong, Shenzhen · Chinese University of Hong Kong
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
54
total citations
- FWCI
- 57.91
- Percentile
- 100%
- References
- 226
Citations per year
Authors
3Topics & keywords
Topics
Keywords
- Medicine
- Disease
- Intensive care medicine
- Fatty liver
- Bioinformatics
- Internal medicine
- Biology
No related works found for this paper.